Medtech Talk

By HealthegyBusiness Investing

Favorites
39
Followers
Typical duration
57 min
per episode

Based on Podcast App listening data

Medtech Talk episodes

April 04, 2018 Baxter Ventures VP Anne Sissel Says Strategic Investors Can Help Start-Ups Reach Their Potential
Anne Sissel, vice president of Baxter Ventures, says she followed the numbers into Medtech. Now, she enjoys using the strategic's capital to help start-ups find ways to curtail costs and create new treatments for dreadful diseases.
34 min
March 27, 2018CEO Jim Buck Says Mardil Medical is Using Familiar Script to Rewrite the Rules on Treating FMR
Jim Buck, President and CEO of Mardil Medical, shares his personal and professional Medtech stories. The common thread? He doesn't give up. One result may be Mardil pushing for the rebirth of a once high-flying Medtech technology.

In this podcast you'll hear:

His tragic, but uplifting path to Medtech.
Where his first stint as CEO went wrong.
How he came to Mardil.
How he believes Mardil will succeed where others haven't.
53 min
March 23, 2018 Lightstone's Jason Lettmann Compares and Contrasts US, Irish Medtech Scenes After Three Years Abroad
When we last spoke with Jason Lettmann, general partner at Lightstone Ventures, he had just set up his firm's shop in Ireland. Three years later, the VC returns to Menlo Park and shares his Medtech observations from abroad. In this podcast, Lettmann compares the entrepreneurial infrastructure in the US with Ireland. He also discusses Lightstone's recent fund and tries to explain why he doesn't tweet.
28 min
March 06, 2018 CEO Stevens Says HeartFlow Took No Shortcuts to Commercialization, Raising $240 million Series E
John H. Stevens, MD, was too excited to sleep when he first heard what HeartFlow's technology could potentially do. Eight years later, he's sleeping a lot better, having secured $240 million to fund the company's commercial rollout of the HeartFlow Analysis system.

Overview: HeartFlow has built a strong financial argument for its imaging system.
Surprises: This stuff belongs on Star Trek. Very cool.
Takeaway: "There are no shortcuts."
36 min
February 27, 2018 Zenflow CEO Damiano Shares Start-up's Origins, Success in Building the Right Series A Syndicate
The Stanford Biodesign program created another promising start-up in Zenflow. Co-founder and CEO Nick Damiano explains how the program's fellows identified the opportunity in BPH and found the right tech to excite investors. Zenflow drew some early capital from unusual sources before embarking on an exhausting pursuit of the right Series A syndicate. Damiano shares some advice for other capital-hungry start-ups.

Overview: Great to see a monster Medtech Series A!
Surprises: Zenflow is working out of some offices with great karma.
Regrets: None. I'm feeling good about this one. I could have asked about the broader team.
34 min
February 16, 2018 LRVHealth Tapping Providers for New $100 Million Fund
Tripp Peake co-founded Long River Ventures in 2000, just before the tech and venture capital industries took a dive. The firm survived, thrived, and is very much alive raising a $100 million fund under a new brand, LRVHealth. The new name and tight healthcare focus reflects the firm's strong connections to hospital networks and other healthcare institutions making up its limited partner base. With a broader investment team and new purpose, LRVHealth is looking to connect healthcare innovators and end-users.

Overview: More money for Series A rounds. Good news!
Surprises: I didn't know the origin of the Long River name.
Regrets: A question or two about LRVHealth's existing portfolio would have been nice.

Enjoy the podcast!
37 min
February 06, 2018 Pixium CEO Sees Great Promise for PRIMA Implant
Khalid Ishaque says Bioelectronic Medicine has made great strides in treating hearing loss, depression, and other maladies and shows great promise in treating neurological disorders like Alzheimer's disease. Yet, most people still see it as more science fiction than science fact. But that's changing. "What we are demonstrating with advances in miniaturization, imaging, and increased understanding of the cellular pathways and the brain is that what was once considered impossible is becoming possible," he declares.

Overview: Pixium Vision is making great progress with its PRIMA subretinal implant.
Surprises: I thought the study was limited to Europe, but the company will be enrolling patients in Pittsburgh too.
Regrets: I should have asked a bit more about the technology's origins.
34 min
January 29, 2018 SVB’s Numbers Guru Jon Norris Points to More Investors, Stronger Exits Facing Medtech in 2018
Hard to find anyone working harder than Jonathan Norris to help us see the forest for the trees.
Jon is a fixture at many conferences including – thankfully – the upcoming Medtech Conference on May 31. But we wanted to get to his insights early. In this Medtech Talk Podcast, Jon and I discuss his report, “Trends in Healthcare Investments and Exits 2018.”
Overview: Jon shares some positive views for Medtech. Good to hear.
Surprises: I didn’t know Jon’s initial career choice.
Regrets: I didn’t get to ask how his pitching arm is doing. Jon still plays ball on a regular basis.
Enjoy the podcast!
42 min
January 23, 2018 New Metavention CEO Todd Berg Talks M&A, Raising Capital, and Why He’s Excited to Join the Start-up
Todd Berg has a bit of a winning streak going. Berg worked at three Medtech start-ups prior to accepting the CEO post at exciting new start-up Metavention, and all three companies would be acquired including Torax Medical, the GERD company Berg led from start to finish.What led Berg to Medtech? Why did he co-found Torax? How did he find success raising capital? How is he approaching his new challenge leading Metavention, which is developing a novel, new potential treatment for type 2 diabetes?
36 min
January 08, 2018 Fractyl’s Rajagopalan Shares Fund-Raising Philosophy
What Went into Fractyl’s $44 million Round? CEO and co-founder Harith Rajagopalan, MD, PhD, discusses his approach to raising new capital and to building the right board.
37 min